Wolff Stefani has filed 8 insider transactions across 1 company since January 2023.
Most recent transaction: a option exercise of 962 shares of Nurix Therapeutics, Inc. ($NRIX) on April 30, 2023.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 30, 2023 | Nurix Therapeutics, Inc. | $NRIX | Wolff Stefani | EVP and COO | M | Common Stock | 962 | $0.00 | 6,455.0000 | 48,607,990 | 17.51% | 0.00% |
| May 1, 2023 | Nurix Therapeutics, Inc. | $NRIX | Wolff Stefani | EVP and COO | S | Common Stock | 342 | $9.88 | 6,113.0000 | 48,607,990 | 5.30% | 0.00% |
| April 30, 2023 | Nurix Therapeutics, Inc. | $NRIX | Wolff Stefani | EVP and COO | M | Restricted Stock Units | 962 | $0.00 | 10,582.0000 | 48,607,990 | 8.33% | 0.00% |
| Feb. 14, 2023 | Nurix Therapeutics, Inc. | $NRIX | Wolff Stefani | EVP and COO | A | Employee Stock Option (right to buy) | 88900 | $0.00 | 88,900.0000 | 48,607,990 | 9999.99% | 0.18% |
| Feb. 14, 2023 | Nurix Therapeutics, Inc. | $NRIX | Wolff Stefani | EVP and COO | A | Restricted Stock Units | 24000 | $0.00 | 24,000.0000 | 48,607,990 | 9999.99% | 0.05% |
| Jan. 30, 2023 | Nurix Therapeutics, Inc. | $NRIX | Wolff Stefani | EVP and COO | M | Common Stock | 962 | $0.00 | 4,364.0000 | 48,607,990 | 28.28% | 0.00% |
| Jan. 30, 2023 | Nurix Therapeutics, Inc. | $NRIX | Wolff Stefani | EVP and COO | S | Common Stock | 424 | $11.78 | 3,940.0000 | 48,607,990 | 9.72% | 0.00% |
| Jan. 30, 2023 | Nurix Therapeutics, Inc. | $NRIX | Wolff Stefani | EVP and COO | M | Restricted Stock Units | 962 | $0.00 | 11,544.0000 | 48,607,990 | 7.69% | 0.00% |